NCT03118544 - REduction of Contrast Via DyeVert Used in CTO Procedures | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 26, 2017

Primary Completion Date

February 2, 2018

Study Completion Date

February 2, 2018

Conditions

Chronic Total Occlusion of Coronary Artery

Interventions

DEVICE

DyeVert System

The DyeVert System (Osprey Medical, Inc) consists of a Contrast Monitoring Wireless Display (CMW) and the DyeVert Plus Disposable Kit which is inclusive of a disposable single-use sterile Smart Syringe and DyeVert Plus Module.

Trial Locations (3)

55407

Abbott Northwestern Hospital, Minneapolis

Minneapolis Heart Institute Foundation, Minneapolis

Minneapolis Heart Institute, Minneapolis